4512

Wakamoto Pharmaceutical Co., Ltd.

わかもと製薬株式会社
Pharmaceutical
Wakamoto Pharmaceutical Co.,Ltd. engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan. The company offers Strong and Granule Wakamoto, gastrointestinal drugs for digestion, intestinal regulation, and nutritional supplementation, as well as Wakamoto Intestinal Remedy drug. It also provides AVANTBISE oral tablets, a supplement of bacteria to restore the balance of oral flora; and medicated toothpaste. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co.,Ltd. in July 1943. Wakamoto Pharmaceutical Co.,Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.
← Companies
Price
¥279
Market Cap
¥9.7B
Ent. Value
¥8.1B
Net Cash
¥1.6B
Shares Out.
34.8M
P / E
42.7×
EV / EBIT
31.8×
P / Book
0.81×
P / NCAV
1.88×
Div. Yield
2.51%
Financials
Metric FY 2025
TDnet 		FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗ 		FY 2021
EDINET ↗
Net Sales ¥9.9B ¥7.8B ¥7.7B ¥8.7B ¥8.4B
Cost of Sales ¥5.2B ¥4.2B ¥4.1B ¥4.6B ¥4.0B
Gross Profit ¥4.7B ¥3.6B ¥3.6B ¥4.1B ¥4.4B
SG&A ¥4.5B ¥4.1B ¥3.8B ¥4.0B ¥4.4B
Operating Income ¥256M ¥-458M ¥-196M ¥141M ¥-13M
Non-Operating Income ¥70M ¥64M ¥71M ¥119M ¥106M
Dividend Income — ¥48M ¥54M ¥48M ¥45M
Interest Income — ¥1M ¥0M ¥0M ¥0M
Non-Operating Expenses — ¥16M ¥37M ¥18M ¥20M
Interest Expense — ¥1M ¥1M ¥1M ¥1M
Ordinary Income ¥256M ¥-409M ¥-162M ¥243M ¥72M
Pre-tax Income ¥256M ¥7M ¥159M ¥212M ¥285M
Income Taxes ¥29M ¥-57M ¥50M ¥73M ¥46M
Current Tax — ¥18M ¥18M ¥65M ¥23M
Deferred Tax — ¥-75M ¥32M ¥9M ¥24M
Net Income (owners) ¥227M ¥64M ¥109M ¥138M ¥239M
EBITDA ¥698M ¥-28M ¥216M ¥587M ¥457M
EPS ¥6.54 ¥1.85 ¥3.13 ¥3.98 ¥6.87
Shares Outstanding — 34.8M 34.8M 34.8M 34.8M
Shares Issued (total) — 34.8M 34.8M 34.8M 34.8M